全文获取类型
收费全文 | 2016篇 |
免费 | 124篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 36篇 |
妇产科学 | 18篇 |
基础医学 | 226篇 |
口腔科学 | 47篇 |
临床医学 | 181篇 |
内科学 | 372篇 |
皮肤病学 | 12篇 |
神经病学 | 238篇 |
特种医学 | 89篇 |
外科学 | 370篇 |
综合类 | 21篇 |
预防医学 | 195篇 |
眼科学 | 23篇 |
药学 | 133篇 |
中国医学 | 4篇 |
肿瘤学 | 158篇 |
出版年
2023年 | 23篇 |
2022年 | 11篇 |
2021年 | 57篇 |
2020年 | 36篇 |
2019年 | 62篇 |
2018年 | 68篇 |
2017年 | 34篇 |
2016年 | 54篇 |
2015年 | 44篇 |
2014年 | 55篇 |
2013年 | 101篇 |
2012年 | 121篇 |
2011年 | 151篇 |
2010年 | 73篇 |
2009年 | 61篇 |
2008年 | 102篇 |
2007年 | 96篇 |
2006年 | 96篇 |
2005年 | 64篇 |
2004年 | 86篇 |
2003年 | 67篇 |
2002年 | 77篇 |
2001年 | 37篇 |
2000年 | 39篇 |
1999年 | 32篇 |
1998年 | 11篇 |
1997年 | 10篇 |
1996年 | 12篇 |
1995年 | 9篇 |
1994年 | 16篇 |
1992年 | 34篇 |
1991年 | 37篇 |
1990年 | 25篇 |
1989年 | 32篇 |
1988年 | 14篇 |
1987年 | 9篇 |
1985年 | 15篇 |
1984年 | 10篇 |
1983年 | 16篇 |
1982年 | 9篇 |
1980年 | 9篇 |
1979年 | 18篇 |
1978年 | 10篇 |
1976年 | 8篇 |
1975年 | 9篇 |
1972年 | 12篇 |
1966年 | 7篇 |
1933年 | 7篇 |
1930年 | 8篇 |
1915年 | 8篇 |
排序方式: 共有2146条查询结果,搜索用时 203 毫秒
1.
2.
Liam Masterson James Howard Jazmina Gonzalez-Cruz Christopher Jackson Catherine Barnett Lewis Overton Howard Liu Rahul Ladwa Fiona Simpson Margie McGrath Ben Wallwork Terry Jones Christian Ottensmeier Melvin L.K. Chua Chris Perry Rajiv Khanna Benedict Panizza Sandro Porceddu Matt Lechner 《International journal of cancer. Journal international du cancer》2020,146(8):2305-2314
Now is an exciting era of development in immunotherapy checkpoint inhibitors and their effect on the treatment of NPC. While the general prognosis of R/M disease is poor, immunotherapy offers some promise in a malignancy associated with EBV and characterized by a peritumoural immune infiltrate. Our study aims to review past and on-going clinical trials of monoclonal antibody therapies against the checkpoint inhibitors (e.g. PD1 and CTLA-4), in R/M NPC. All randomized and nonrandomized controlled trials involving immune checkpoint inhibitor interventions for treatment of NPC were included in the study. We utilized a validated “risk of bias” tool to assess study quality. Four separate Phase I–II trials report the potential of PD1 inhibitor treatment for patients with NPC. Within the observed groups, camrelizumab combined with chemotherapy achieved an objective response in 91% of patients as first-line treatment for metastatic NPC (PFS 68% at 1-year) but this was associated with a high rate of grade >3 adverse events (87%; CTCAE version 4.03). The remaining three studies focused on recurrent NPC disease in patients who had received at least one line of prior chemotherapy. Within this group, camrelizumab monotherapy achieved an objective response in 34% of patients (PFS 27% at 1-year; range across all three studies 20.5–34%). No NPC trial has yet reported on specific outcomes for non-PD1 checkpoint inhibitors but 11 on-going studies include alternative targets (e.g. PD-L1/CTLA-4) as combination or monotherapy treatments. In considering checkpoint immunotherapies for NPC, initial results show promise for anti-PD1 interventions. Further phase I–III trials are in progress to clarify clinical outcomes, fully determine safety profiles, and optimize drug combinations and administration schedules. 相似文献
3.
Benedict M Devereaux Andrew C F Taylor Eugene Athan David J Wallis Robyn R Brown Sue M Greig Fiona K Bailey Karen Vickery Elizabeth Wardle Dianne M Jones 《Journal of gastroenterology and hepatology》2019,34(12):2086-2089
Concern has been raised regarding the use of simethicone, a de‐foaming agent, during endoscopic procedures. Following reports of simethicone residue in endoscope channels despite high level disinfection, an endoscope manufacturer recommended that it not be used due to concerns of biofilm formation and a possible increased risk of microorganism transmission. However, a detailed mucosal assessment is essential in performing high‐standard endoscopic procedures. This is impaired by bubbles within the gastrointestinal lumen. The Gastroenterological Society of Australia's Infection Control in Endoscopy Guidelines (ICEG) Committee conducted a literature search utilizing the MEDLINE database. Further references were sourced from published paper bibliographies. Following a review of the available evidence, and drawing on extensive clinical experience, the multidisciplinary ICEG committee considered the risks and benefits of simethicone use in formulating four recommendations. Published reports have documented residual liquid or crystalline simethicone in endoscope channels after high level disinfection. There are no data confirming that simethicone can be cleared from channels by brushing. Multiple series report benefits of simethicone use during gastroscopy and colonoscopy in improving mucosal assessment, adenoma detection rate, and reducing procedure time. There are no published reports of adverse events related specifically to the use of simethicone, delivered either orally or via any endoscope channel. An assessment of the risks and benefits supports the continued use of simethicone during endoscopic procedures. Strict adherence to instrument reprocessing protocols is essential. 相似文献
4.
5.
Joshua A. De Bono David C. McGiffin Benedict J. F. Waldron Angeline S. Leet Atsuo Doi 《Echocardiography (Mount Kisco, N.Y.)》2019,36(2):419-421
Aortic root spontaneous echo contrast is a rare but significant finding. We report a 31‐year‐old female who was placed on venoarterial extracorporeal membrane oxygenation emergently for acute mitral regurgitation secondary to papillary muscle rupture. Following stabilization, subsequent transesophageal echocardiography suggested aortic root thrombus and prompted emergent surgery. However, further inspection with intraoperative transesophageal echocardiography revealed a spontaneous echo contrast which aided us in the intraoperative decision making. 相似文献
6.
Journal of Neuro-Oncology - Due to the infiltrative nature of glioblastoma (GBM) outside of the contrast-enhancing region on MRI, there is interest in exploring supratotal resections (SpTR) that... 相似文献
7.
8.
Amanda C. Hahn Claire I. Fisher Lisa M. DeBruine Benedict C. Jones 《Archives of sexual behavior》2016,45(4):871-875
Studies of the sex-specificity of sexual arousal in adults (i.e., the tendency to respond more strongly to preferred-sex individuals than non-preferred sex individuals) have suggested that heterosexual men, homosexual men, and homosexual women show stronger sex-specific responses than do heterosexual women. Evidence for a similar pattern of results in studies investigating the reward value of faces is equivocal. Consequently, we investigated the effects of (1) sexual orientation (homosexual vs. heterosexual), (2) sex (male vs. female), (3) image sex (preferred-sex vs. non-preferred-sex), and (4) the physical attractiveness of the individual shown in the image on the reward value of faces. Participants were 130 heterosexual men, 130 homosexual men, 130 heterosexual women, and 130 homosexual women. The reward value of faces was assessed using a standard key-press task. Multilevel modeling of responses indicated that images of preferred-sex individuals were more rewarding than images of non-preferred-sex individuals and that this preferred-sex bias was particularly pronounced when more physically attractive faces were presented. These effects were not qualified by interactions involving either the sexual orientation or the sex of our participants, however, suggesting that the preferred-sex bias in the reward value of faces is similar in heterosexual men, homosexual men, heterosexual women, and homosexual women. 相似文献
9.
10.
Roman Kia Rahimi-Nedjat Andrea Tuettenberg Keyvan Sagheb Carmen Loquai Benedict Rybczynski Stephan Grabbe Christian Walter Bilal Al-Nawas 《Journal of cranio-maxillo-facial surgery》2021,49(4):317-322
To investigate factors that affect and also decrease the duration for recurrences and secondary tumors in cSCC.A retrospective study was conducted for all patients who were treated for a cSCC of the head and neck between 2009 and 2016. Anamnestic as well as epidemiological and histological data were noted and correlated with the occurrence of recurrences and secondary cancers. The duration between surgery and these events was used to determine if histological factors accelerate their occurrence.The highest risk for recurrences was seen in patients with previous skin cancers (RR 3.23). Histological ulceration (p = 0.003) and grading (p = 0.031) of the tumor were found as significant factors accelerating the time to relapse. Surrounding chronic precancerotic lesions (p < 0.001) and poor tumor grading (p = 0.035) were found as significant factors accelerating the time until a secondary cSCC was observed.Known risk factors increase not only the risk for a cSCC but also for recurrences. Specific histologic findings can help to adjust follow-up intervals to identify recurrences and secondary tumors at an early stage as these were shown to decrease the duration for a further event. 相似文献